Scott Biller Net Worth & Insider Trades
Scott Biller - Chief Scientific Officer, Agios Pharmaceuticals Inc
What is Scott Biller's Net Worth?
The current estimated net worth of Agios Pharmaceuticals Inc's Chief Scientific Officer, Scott Biller, is estimated to be about $25.07M . Scott Biller owns about 79,570 units of Agios Pharmaceuticals Inc common stock. In the last 5 years at Agios Pharmaceuticals Inc, Scott Biller has sold an estimated value of $24.45M worth.
What is Scott Biller's Past Insider Trading?
Scott Biller's largest purchase order was 15,177 units , worth over $480.2K on May 29, 2018. Scott Biller's largest sale order was 32,500 units , worth over $2.11M on November 16, 2016. In total, Scott Biller has made about 77 transactions over 5 years of their time at Agios Pharmaceuticals Inc. Scott Biller usually trades in June, with the busiest year in 2014. The most recent transaction was a sale order of 3,000 units , worth over $203.14K on April 9, 2019.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Scott Biller
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Scott Biller's Salary in 2020?
As Chief Scientific Officer of Agios Pharmaceuticals Inc, Scott Biller has a total base salary of $500,000 . Scott Biller received compensation valued at about $769,328 in 2020 after becoming Chief Scientific Officer. The vast majority of their compensation came in the form of other earnings, plans or compensations of $258,750 , and other compensation of $10,578 .
What is Scott Biller's' Mailing Address?
- Mailing address is C/o Agios Pharmaceuticals, Inc. 38 Sidney Street, 2nd Floor Cambridge MA 02139 MA
Agios Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Jacqualyn A. Fouse, Ph.D. | 2020 | $746,750 | - | $1,751,340 | $4,593,651 | $509,657 | $10,577 | $7,611,975 |
| Jacqualyn A. Fouse, Ph.D. | 2019 | $664,583 | - | $2,538,474 | $12,875,608 | $424,125 | $105,204 | $16,607,994 |
| Jacqualyn A. Fouse, Ph.D. | 2018 | - | - | - | - | - | - | - |
| Jonathan Biller | 2020 | $500,000 | - | - | - | $258,750 | $10,578 | $769,328 |
| Jonathan Biller | 2019 | $39,583 | $110,000 | $1,008,334 | $2,025,036 | - | $936 | $3,183,889 |
| Jonathan Biller | 2017 | - | - | - | - | - | - | - |
| Christopher Bowden, M.D. | 2020 | $515,007 | - | $618,120 | $1,508,875 | $243,341 | $9,203 | $2,894,546 |
| Christopher Bowden, M.D. | 2019 | $490,539 | - | $915,590 | $1,609,989 | $198,668 | $12,422 | $3,227,208 |
| Christopher Bowden, M.D. | 2018 | $467,141 | - | $641,025 | $1,746,517 | $262,767 | $11,280 | $3,128,730 |
| Bruce Car, Ph.D. | 2020 | $494,318 | - | $833,301 | $1,499,943 | $236,250 | $164,231 | $3,228,043 |
| Bruce Car, Ph.D. | 2019 | - | - | - | - | - | - | - |
| Bruce Car, Ph.D. | 2018 | - | - | - | - | - | - | - |
| Andrew Hirsch | 2020 | $361,234 | - | $618,120 | $1,508,875 | - | $397,893 | $2,886,122 |
| Andrew Hirsch | 2019 | $500,476 | - | $1,923,145 | $1,609,989 | $202,693 | $12,528 | $4,248,831 |
| Andrew Hirsch | 2018 | $471,329 | - | $641,025 | $1,746,517 | $265,123 | $12,864 | $3,136,858 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1439222/000119312521110205/d71514ddef14a.htm
What are Agios Pharmaceuticals Inc's Past Insider Trades?
Agios Pharmaceuticals Inc's most recent insider trade came on August 21, 2023 by James Burns who sold 6,395 units worth $168.06K . In the last 10 years, insiders at Agios Pharmaceuticals Inc have sold an estimated value of $175.4M and bought an estimated value of $173.58M worth of shares. Insider trading is most common in June, with the busiest year in 2014. The most active traders at the company are David Schenkein, Director, Scott Biller, Chief Scientific Officer, and John Duncan Higgons, Chief Operating Officer .
AGIOS PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||